Fludeoxyglucose Injection
Product Images NDC 62072-008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose (NDC 62072-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kreitchman Pet Center, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of Product And Container Label (Fdg Label)

Image Of Product And Container Label (Fdg Label)
This is a description of a Multiple-Dose Vial that contains Fludeoxyglucose F18 Injection, a radiopharmaceutical used for Positron Emission Tomography (PET) imaging. The vial is sterile, non-pyrogenic, and contains 0.37 to 3.7 GBq of the substance, along with sodium chloride and citrate. The vial is for intravenous use only and should not be used if cloudy or contains particulate matter. The Fludeoxyglucose [18F] has a half-life of 109.7 min and the correct dosage should be calculated from the date and time of calibration. The vial should be stored at 25°C and aseptically handled. The activity concentration of the substance is measured in mCi per mL. The expiration time of the substance is 7.5 hours after the End of Synthesis (EOS) and the vial should be stored in a shielded container. This product was manufactured by the Kreitchman PET Center in the City of New York.*
FDA Label Image

Image Of Chemical Structure (Fdg Structure)

Image Of Chemical Structure (Fdg Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.